Medicine and Dentistry
Patient
100%
Hepatitis B Virus
71%
Liver Cirrhosis
57%
Combination Therapy
42%
Lamivudine
42%
Hepatitis B
28%
Antiviral Therapy
28%
Carcinoma
14%
Antigen
14%
Virus DNA
14%
Hepatitis B Antigen
14%
Monotherapy
14%
Development
14%
Vaccine
14%
Liver Transplantation
14%
Drug
14%
Chemotherapeutic Agent
14%
Reverse-Transcriptase Inhibitor
14%
Therapeutic Procedure
14%
Liver
14%
Woman
14%
Mutant
14%
Hospital
14%
Disease
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
71%
Liver Cirrhosis
57%
Lamivudine
42%
Hepatitis B
28%
Monotherapy
14%
Antigen
14%
Carcinoma
14%
Drug
14%
Vaccine
14%
Virus DNA
14%
RNA Directed DNA Polymerase Inhibitor
14%
Hepatitis B Surface Antigen
14%
Immunology and Microbiology
Hepatitis B Virus
85%
Liver
28%
Antigen
14%
HBsAg
14%
DNA Virus
14%
Vaccine Efficacy
14%
Development
14%
Health
14%
Mutant
14%
Liver Transplantation
14%
Viral Disease
14%
Neuroscience
Lamivudine
42%
Antivirals
28%
Antigen
14%
DNA Virus
14%
Hepatitis B Surface Antigen
14%
Reverse Transcriptase Inhibitors
14%
Biochemistry, Genetics and Molecular Biology